PASSAGE BIO, INC. Shares Outstanding (Cover Page)
PASSAGE BIO, INC. (PASG) had Shares Outstanding (Cover Page) of 3.22 million shares as of 2026-08-05, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-10
- 2026-08-05: Entity Common Stock, Shares Outstanding 3.22M shares.
- 2026-05-07: Entity Common Stock, Shares Outstanding 3.21M shares.
- 2026-02-26: Entity Common Stock, Shares Outstanding 3.21M shares.
- 2025-11-06: Entity Common Stock, Shares Outstanding 3.18M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-05 | 3.22M shares 10-Q · filed 2026-08-10 |
| 2026-05-07 | 3.21M shares 10-Q · filed 2026-05-12 |
| 2026-02-26 | 3.21M shares 10-K · filed 2026-03-03 |
| 2025-11-06 | 3.18M shares 10-Q · filed 2025-11-10 |
| 2025-08-07 | 3.18M shares 10-Q · filed 2025-08-12 |
| 2025-05-08 | 62.15M shares 10-Q · filed 2025-05-13 |
| 2025-02-27 | 62.15M shares 10-K · filed 2025-03-04 |
| 2024-11-08 | 61.77M shares 10-Q · filed 2024-11-13 |
| 2024-08-05 | 61.77M shares 10-Q · filed 2024-08-08 |
| 2024-05-09 | 61.64M shares 10-Q · filed 2024-05-14 |
| 2024-02-28 | 55.60M shares 10-K · filed 2024-03-04 |
| 2023-11-08 | 54.82M shares 10-Q · filed 2023-11-13 |
| 2023-08-02 | 54.81M shares 10-Q · filed 2023-08-07 |
| 2023-05-09 | 54.63M shares 10-Q · filed 2023-05-11 |
| 2023-03-02 | 54.62M shares 10-K · filed 2023-03-06 |
| 2022-11-04 | 54.55M shares 10-Q · filed 2022-11-10 |
| 2022-08-01 | 54.46M shares 10-Q · filed 2022-08-04 |
| 2022-05-12 | 54.31M shares 10-Q · filed 2022-05-16 |
| 2022-03-01 | 54.29M shares 10-K · filed 2022-03-03 |
| 2021-11-01 | 54.11M shares 10-Q · filed 2021-11-04 |
| 2021-08-03 | 54.09M shares 10-Q · filed 2021-08-05 |
| 2021-05-03 | 53.98M shares 10-Q · filed 2021-05-05 |
| 2021-03-01 | 53.83M shares 10-K · filed 2021-03-03 |
| 2020-11-10 | 45.53M shares 10-Q · filed 2020-11-10 |
| 2020-08-11 | 45.49M shares 10-Q · filed 2020-08-13 |
| 2020-05-08 | 45.35M shares 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |